40,000 infants living with neurological impairment following GBS-associated infections
796
关于报告和相关论文
About the report and linked papers
797
《B组链球菌疫苗的全球价值》报告对当前B组链球菌负担的全球估计数作了更新。
The global value of Group B streptococcus vaccine report updates the current global estimates of the GBS burden, first published in 2017 by WHO with LSHTM, and funded by the Bill & Melinda Gates Foundation.
For the first time, these new estimates include data on preterm births associated with GBS, as well as the risk of neurodevelopmental impairment in GBS survivors, based on new data from Denmark and five low- and middle-income countries (Argentine, India, Kenya, Mozambique and South Africa).
Associated with this report, a series of nine papers carried out by 61 authors from 6 continents have been published in the Clinical Infectious Disease journal supplement – ‘Every Country, Every Family: Group B Streptococcal DiseaseWorldwide’.
800
这些论文提供了有关B组链球菌的更多数据,以及B组链球菌病对家庭带来的高昂费用。
These papers provide more in-depth data on GBS, as well as the acute costs of GBS illness for families.